Institutional investors purchased a net $376.1 thousand shares of AVEO during the quarter ended December 2012 and now own 69.76% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELLINGTON MANAGEMENT CO. LLP Bought 1.2 Million shares of Aveo Pharmaceuticals Inc
BLACKROCK FUND ADVISORS Bought 1.1 Million shares of Aveo Pharmaceuticals Inc